These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 34187402

  • 1. Cigarette smoking may accelerate the progression of IgA nephropathy.
    Wang S, Qin A, Pei G, Jiang Z, Dong L, Tan J, Tan L, Tang Y, Qin W.
    BMC Nephrol; 2021 Jun 29; 22(1):239. PubMed ID: 34187402
    [Abstract] [Full Text] [Related]

  • 2. High Neutrophil-To-Lymphocyte Ratio Is an Independent Risk Factor for End Stage Renal Diseases in IgA Nephropathy.
    Wang S, Dong L, Pei G, Jiang Z, Qin A, Tan J, Tang Y, Qin W.
    Front Immunol; 2021 Jun 29; 12():700224. PubMed ID: 34456912
    [Abstract] [Full Text] [Related]

  • 3. Association of obesity with the development of end stage renal disease in IgA nephropathy patients.
    Wang S, Qin A, Dong L, Tan J, Zhou X, Qin W.
    Front Endocrinol (Lausanne); 2023 Jun 29; 14():1094534. PubMed ID: 37020590
    [Abstract] [Full Text] [Related]

  • 4. Lower serum bilirubin is associated with poor renal outcome in IgA nephropathy patients.
    Jiang Z, Tan J, Wang S, Dong L, Han X, Tang Y, Qin W.
    Int J Med Sci; 2021 Jun 29; 18(13):2964-2970. PubMed ID: 34220324
    [Abstract] [Full Text] [Related]

  • 5. Positive renal familial history in IgA nephropathy is associated with worse renal outcomes: a single-center longitudinal study.
    Sato Y, Tsukaguchi H, Higasa K, Kawata N, Inui K, Linh TNT, Quynh TTH, Yoshihiko I, Koiwa F, Yoshimura A.
    BMC Nephrol; 2021 Jun 19; 22(1):230. PubMed ID: 34147067
    [Abstract] [Full Text] [Related]

  • 6. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.
    Tian S, Yang X, Luo J, Guo H.
    Int Immunopharmacol; 2020 Nov 19; 88():106896. PubMed ID: 33182045
    [Abstract] [Full Text] [Related]

  • 7. Cigarette smoking and progression of IgA nephropathy.
    Yamamoto R, Nagasawa Y, Shoji T, Iwatani H, Hamano T, Kawada N, Inoue K, Uehata T, Kaneko T, Okada N, Moriyama T, Horio M, Yamauchi A, Tsubakihara Y, Imai E, Rakugi H, Isaka Y.
    Am J Kidney Dis; 2010 Aug 19; 56(2):313-24. PubMed ID: 20471735
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Association of high body mass index with development of interstitial fibrosis in patients with IgA nephropathy.
    Wu C, Wang AY, Li G, Wang L.
    BMC Nephrol; 2018 Dec 29; 19(1):381. PubMed ID: 30594167
    [Abstract] [Full Text] [Related]

  • 11. The prognostic value of the systemic immune inflammation index in patients with IgA nephropathy.
    Zhai Y, Sun S, Zhang W, Tian H.
    Ren Fail; 2024 Dec 29; 46(2):2381613. PubMed ID: 39039867
    [Abstract] [Full Text] [Related]

  • 12. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H.
    Nephrology (Carlton); 2008 Jun 29; 13(3):242-6. PubMed ID: 18221258
    [Abstract] [Full Text] [Related]

  • 13. Glomerular C4 deposition and glomerulosclerosis predict worse renal outcomes in Chinese patients with IgA nephropathy.
    Yang Y, Tang X, Yang Y, Li X, Li L, Huang K, Li Y, Li J, Fu P.
    Ren Fail; 2020 Nov 29; 42(1):629-637. PubMed ID: 32660366
    [Abstract] [Full Text] [Related]

  • 14. Measures of Urinary Protein and Albumin in the Prediction of Progression of IgA Nephropathy.
    Zhao YF, Zhu L, Liu LJ, Shi SF, Lv JC, Zhang H.
    Clin J Am Soc Nephrol; 2016 Jun 06; 11(6):947-955. PubMed ID: 27026518
    [Abstract] [Full Text] [Related]

  • 15. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
    Chai L, Cai K, Wang K, Luo Q.
    J Clin Lab Anal; 2021 Jun 06; 35(6):e23774. PubMed ID: 33951240
    [Abstract] [Full Text] [Related]

  • 16. High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.
    Gong WY, Liu M, Luo D, Liu FN, Yin LH, Li YQ, Zhang J, Peng H.
    BMC Nephrol; 2019 Apr 30; 20(1):150. PubMed ID: 31039758
    [Abstract] [Full Text] [Related]

  • 17. Clinical outcomes, when matched at presentation, do not vary between adult-onset Henöch-Schönlein purpura nephritis and IgA nephropathy.
    Oh HJ, Ahn SV, Yoo DE, Kim SJ, Shin DH, Lee MJ, Kim HR, Park JT, Yoo TH, Kang SW, Choi KH, Han SH.
    Kidney Int; 2012 Dec 30; 82(12):1304-12. PubMed ID: 22895518
    [Abstract] [Full Text] [Related]

  • 18. The effect of renin-angiotensin system blockade on the incidence of end-stage renal disease in IgA nephropathy.
    Tanaka S, Ninomiya T, Katafuchi R, Masutani K, Nagata M, Tsuchimoto A, Hirakata H, Kitazono T, Tsuruya K.
    Clin Exp Nephrol; 2016 Oct 30; 20(5):689-698. PubMed ID: 26564155
    [Abstract] [Full Text] [Related]

  • 19. Association of C4d deposition with clinical outcomes in IgA nephropathy.
    Espinosa M, Ortega R, Sánchez M, Segarra A, Salcedo MT, González F, Camacho R, Valdivia MA, Cabrera R, López K, Pinedo F, Gutierrez E, Valera A, Leon M, Cobo MA, Rodriguez R, Ballarín J, Arce Y, García B, Muñoz MD, Praga M, Spanish Group for Study of Glomerular Diseases (GLOSEN).
    Clin J Am Soc Nephrol; 2014 May 30; 9(5):897-904. PubMed ID: 24578331
    [Abstract] [Full Text] [Related]

  • 20. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
    Le W, Liang S, Hu Y, Deng K, Bao H, Zeng C, Liu Z.
    Nephrol Dial Transplant; 2012 Apr 30; 27(4):1479-85. PubMed ID: 21965586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.